Expansion would make DaVita the largest dialysis services provider in Latin America
DaVita Inc, a leading provider of kidney care services, announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia, and its entry into Chile and Ecuador. The deal, which is consistent with DaVita’s disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD. The transaction in Chile closed effective March 5th. The transactions in Ecuador, Colombia and Brazil remain subject to each country’s respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.
Upon completion of the transactions and when combined with DaVita’s existing Latin American operations in Brazil and Colombia, the Company will have more than 15,000 DaVita teammates providing high-quality clinical care to more than 60,000 patients in more than 270 clinics. As a result, DaVita would become the largest dialysis services provider in Latin America.
“As we welcome thousands of dedicated caregivers to DaVita, we will continue our strategy of combining our global clinical expertise with strong investment in our local teams to deliver a sustainable and valuable contribution to the healthcare communities we serve,” said Robert Lang, president of DaVita International. “Delivering outstanding clinical care for individuals suffering from kidney disease is our most important priority. We look forward to building on our existing market expertise and the established quality of these centers through this transition.”
DaVita’s international operations provide life-sustaining care in 12 countries outside of the United States and, assuming completion of the transactions announced today, will have grown from serving 23,000 patients in 2017 to serving more than 79,000 patients.
